LINC02882

Across TCGA pan-cancer cohorts, LINC02882 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated LINC02882 data layer compared with 1 for mutation status.

The strongest signal is observed in thymoma (THYM), where higher LINC02882 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02882 expression acts as an unfavorable survival marker, although some lineages such as TGCT and BLCA show a favorable association.

THYM, THCA, and COAD are the cancer types where LINC02882 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	DFS	Median	II,III,IV	0.682	0.921	<.001	93	view →
THCA	DFS	Tertile	III,IV	0.297	0.712	<.001	81	view →
COAD	DFS	Tertile	All	0.595	0.745	<.001	76	view →
UVM	DFS	Tertile	All	0.200	0.763	.011	54	view →
BRCA	OS	Median	All	0.889	0.941	.001	54	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	39	view →
STAD	OS	Median	All	0.425	0.630	.007	37	view →
DLBC	OS	Tertile	II,III,IV	0.430	0.895	.001	36	view →
LIHC	DFS	Median	II,III,IV	0.212	0.451	.002	35	view →
LUAD	OS	Median	All	0.767	0.896	.003	34	view →
UCS	OS	Median	IV	0.302	0.817	.002	24	view →
ACC	OS	Tertile	II,III,IV	0.635	0.907	.010	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

LINC02882–THYM (DFS)

Open the THYM breakdown →